~267 spots leftby Aug 2028

Integrated Behavioral Health for Adolescent Opioid Use Disorder

Palo Alto (17 mi)
Overseen byLeslie A Hulvershorn, MD
Age: Any Age
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: Indiana University
No Placebo Group

Trial Summary

What is the purpose of this trial?This project seeks to address the increasing risk of overdose death, substance use disorder (SUD), and opioid use disorder (OUD) in adolescents. The investigators believe that pediatric primary care providers (PCP) could play an important role in helping youth with SUD because most adolescents see their PCPs for annual wellness visits. However, PCPs have many barriers to treating their young patients with SUD/OUD: lack of training, resources, and support to deliver SUD/OUD services, limited time with patients, and the only available referral options often come with long wait times for an appointment. Through this project, the investigators will build upon an existing Integrated Behavioral Health (IBH) system by offering stigma-reduction interventions and brief SUD interventions within primary care settings. The goal of this project is to learn if clinics participating in an Integrated Behavioral Healthcare Program with SUD resources will increase delivery of effective adolescent SUD care and ultimately lead to better health outcomes when compared to standard primary care treatment. During the first project phase, the research team will gather a Parent and Youth Advisory Board, Primary Care Provider Advisory Board, and Integrated Care Expert Panel (Aim 1) to inform the development and refinement of the primary care-based SUD interventions. The investigators will gather input from national experts, local stakeholders, and PCPs to refine our screening to treatment approach (Aim 2), coupled with stigma reduction activities, within pediatric primary care. During the second project phase, researchers will assess the impact of SUD IBH on PCP behaviors around adolescent SUD intervention. The investigators will interview and survey PCPs, clinic managers, and other clinical staff for willingness to engage in adolescent SUD treatment. The investigators will evaluate implementation outcomes (views toward SUD, stigma attitudes, IBH team dynamics; Aim 3) and effectiveness/reach outcomes (delivery of integrated primary care-based SUD services, the use of brief interventions for adolescents, number of consultation calls, and increased treatment engagement; Aim 4a), along with an exploratory test of local overdose rates for youth (Aim 4b), in order to examine local effects of the new intervention. This project is supported by the HEAL Initiative (https://heal.nih.gov/).

Eligibility Criteria

This trial is for adolescents at risk of or struggling with substance use disorders (SUD) and opioid use disorder (OUD). It's aimed at improving care within pediatric primary care settings. Participants are likely to be those who regularly visit their pediatricians for annual wellness checks.

Inclusion Criteria

I am between 12 and 18 years old and see a doctor at a participating pediatric care team.

Treatment Details

The study tests an Integrated Behavioral Health System enhanced with SUD resources in pediatric primary care. The goal is to see if this system helps doctors provide better SUD/OUD treatment compared to standard practices, potentially leading to improved health outcomes.
2Treatment groups
Experimental Treatment
Active Control
Group I: Integrated Behavioral Health with SUD ResourcesExperimental Treatment1 Intervention
Participating clinics receive a system-level intervention, an Integrated Behavioral Health System with SUD Resources, designed to improve youth connection to substance use treatment.
Group II: Primary Care Practice As UsualActive Control1 Intervention
Data are collected regarding standard primary care practice and outcomes before implementation of SUD resources within the Integrated Behavioral Health System.

Find a clinic near you

Research locations nearbySelect from list below to view details:
Indiana University School of MedicineIndianapolis, IN
Loading ...

Who is running the clinical trial?

Indiana UniversityLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator

References